These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Hospital exposure in a UK population, and its association with bacteraemia. Wyllie DH, Walker AS, Peto TE, Crook DW. J Hosp Infect; 2007 Dec; 67(4):301-7. PubMed ID: 18022283 [Abstract] [Full Text] [Related]
26. Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study. Lee JY, Chong YP, Kim T, Hong HL, Park SJ, Lee ES, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS. J Antimicrob Chemother; 2014 Jul; 69(7):1966-71. PubMed ID: 24695351 [Abstract] [Full Text] [Related]
29. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476 [Abstract] [Full Text] [Related]
30. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases. Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875 [Abstract] [Full Text] [Related]
33. Treatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based study. Chen LY, Chen LK, Chang CW, Kuo SC, Li LF, Chan YJ, Wang FD. Arch Gerontol Geriatr; 2012 Jan; 55(1):152-6. PubMed ID: 21820190 [Abstract] [Full Text] [Related]
34. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study. Mehl A, Åsvold BO, Kümmel A, Lydersen S, Paulsen J, Haugan I, Solligård E, Damås JK, Harthug S, Edna TH. BMC Infect Dis; 2017 Feb 02; 17(1):116. PubMed ID: 28148226 [Abstract] [Full Text] [Related]
35. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. Peralta G, Sánchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, Roiz MP. J Antimicrob Chemother; 2007 Oct 02; 60(4):855-63. PubMed ID: 17644532 [Abstract] [Full Text] [Related]
36. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, Samra Z, Paghis D, Bishara J, Leibovici L. J Antimicrob Chemother; 2010 Dec 02; 65(12):2658-65. PubMed ID: 20947620 [Abstract] [Full Text] [Related]
37. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. Huttunen R, Laine J, Lumio J, Vuento R, Syrjänen J. BMC Infect Dis; 2007 Mar 09; 7():13. PubMed ID: 17349033 [Abstract] [Full Text] [Related]
38. Is MRSA admission bacteraemia community-acquired? A case control study. Miller R, Esmail H, Peto T, Walker S, Crook D, Wyllie D. J Infect; 2008 Mar 09; 56(3):163-70. PubMed ID: 18242713 [Abstract] [Full Text] [Related]
39. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Yaw LK, Robinson JO, Ho KM. Lancet Infect Dis; 2014 Oct 09; 14(10):967-75. PubMed ID: 25185461 [Abstract] [Full Text] [Related]
40. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals. Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Martín-Gandul C, López-Medrano F, de Gopegui ER, Ramón Blanco J, García-Pardo G, Calbo E, Horcajada JP, Granados A, Jover-Sáenz A, Dueñas C, Pujol M, REIPI/GEIM Study Groups. Clin Microbiol Infect; 2014 Apr 09; 20(4):361-7. PubMed ID: 23991832 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]